MedAlliance to be Acquired by Cordis
prnewswire.com
news
2022-10-18 13:00:00

GENEVA, Oct. 18, 2022 /PRNewswire/ -- Swiss-based medical technology company MedAlliance has announced it has entered into an agreement with Cordis for an acquisition which includes an initial investment of $35M and upfront closing payment of $200M, regulatory achievement milestones of up to $125M and commercial milestones of up to $775M through 2029 for a total consideration of up to $1.135 Billion. 


Continue Reading







 






MedAlliance to be Acquired by Cordis36

 



Cordis is a worldwide leader in the development and manufacturing of interventional cardiovascular and endovascular technologies.
